drugset / Trial / NCT05108688
Mirtazapine vs Sumatriptan in the Treatment of Postdural Puncture Headache
RandomizedParallel-groupDouble-blindTreatment
Summary
Postdural puncture headache (PDPH) is a potential complication after spinal anesthesia caused by traction on pain-sensitive structures from low cerebrospinal fluid pressure (intracranial hypotension) following a leak of cerebrospinal fluid at the puncture site. Symptoms of this condition include a bilateral frontal or occipital headache that is worse in the upright position, along with nausea, neck pain, dizziness, visual changes, tinnitus, hearing loss, or radicular symptoms in the arms. This study will examine the efficacy of mirtazapine in in the treatment of PDPH after obstetric surgery under spinal anesthesia and compared its efficacy with that of sumatriptan.
Timeline
- Start
- 2021-11-15
- Primary completion
- 2023-12-20
- Completion
- 2023-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Mirtazapine | Other / unclassified | 30 mg | — |
| Comparator | Sumatriptan | Unknown | 50 mg | — |